CRH : H1 in line but bring on H2…
>H1 2018 earnings in line and sequential improvement in trends - EBITDA totalled € 1.13bn (+1% in absolute terms and like-for-like), broadly in line with our estimate of € 1.1bn and consistent with the group’s Q1 2018 guidance. Cash flow deteriorated to -€ 311m vs -€ 49m in H1 2017 due to WCR (rise in stocks) and taxes on the capital gain on the sale of the distribution business in the US. Net debt nonetheless stood at € 8.05bn, slightly lower than the consensus forec...CRH Medical is engaged in the treatment of hemorrhoids by utilizing its treatment protocol and patented proprietary technology.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.